Early revascularization in acute myocardial infarction complicated by cardiogenic shock

New England Journal of Medicine

Volumn 341, Issue 9, 1999, Pages 625-634

  Hochman, Judith S ^a,k   Sleeper, Lynn A ^b   Webb, John G ^c   Sanborn, Timothy A ^d   White, Harvey D ^e   Talley, J David ^f   Buller, Christopher E ^g   Jacobs, Alice K ^h   Slater, James N ^a   Col, Jacques ⁱ   McKinlay, Sonja M ^b   LeJemtel, Thierry H ^j   Picard, Michael H ^l   Menegus, Mark A ^j   Boland, Jean ^m   Dzavik, Vladimir ⁿ   Thompson, Christopher R ^c   Wong, S Chiu ^o   Steingart, Richard ^p   Forman, Robert ^j   Aylward, Philip E ^q   Godfrey, Emilie ^k   Desvigne Nickens, Patrice ^r   more..

^a Howard Hughes Medical Institute   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c ST PAUL S HOSPITAL   (Canada)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e GREEN LANE HOSPITAL   (New Zealand)

^f UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^g VANCOUVER GENERAL HOSPITAL   (Canada)

^h BOSTON MEDICAL CENTER   (United States)

ⁱ CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^k ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m Centre régional hospitalier de la Citadelle   (Belgium)

ⁿ UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^o NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^p WINTHROP UNIVERSITY HOSPITAL   (United States)

^q FLINDERS MEDICAL CENTRE   (Australia)

^r NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HYPERTENSIVE AGENT; INOTROPIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS GRAFT; COUNTERPULSATION; EMERGENCY TREATMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION; SHORT SURVEY; SURVIVAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; EMERGENCY TREATMENT; FEMALE; HUMANS; INTRA-AORTIC BALLOON PUMPING; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SHOCK, CARDIOGENIC; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0033606918     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199908263410901     Document Type: Short Survey

References (37)

1. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
2. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967; 20:457-64.
3. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995;26:668-74.
4. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 1996;27:1321-6.
5. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78: 1345-51.
6. Verna E, Repetto S, Boscarini M, Ghezzi I, Binaghi G. Emergency coronary angioplasty in patients with severe left ventricular dysfunction or cardiogenic shock after acute myocardial infarction. Eur Heart J 1989;10:958-66.
7. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-14.
8. Yamamoto H, Yahashi Y, Oka Y, et al. Efficacy of percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction complicated by cardiogenic shock. Jpn Circ J 1992;56:815-21.
9. Hibbard MD, Holmes DR Jr, Bailey KR, Reeder GS, Bresnahan JF, Gersh BJ. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992;19:639-46.
10. Guyton RA, Arcidi JM Jr, Langford DA, Morris DC, Lieberman HA, Hatcher CR Jr. Emergency coronary bypass for cardiogenic shock. Circulation 1987;76:Suppl V:V-22-V-27.
11. Bolooki H. Emergency cardiac procedures in patients in cardiogenic shock due to complications of coronary artery disease. Circulation 1989; 76:Suppl II:II-37-II-48.
12. Kirklin JK, Blackstone EH, Zorn GL Jr, et al. Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction. Circulation 1985;72:Suppl II:II-175-II-178.
13. Subramanian VA, Roberts AJ, Zema MJ, et al. Cardiogenic shock following acute myocardial infarction: late function results after emergency cardiac surgery. N Y State J Med 1980;80:947-52.
14. DeWood MA, Notske RN, Hensley GR, et al. Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980;61:1105-12.
15. Dunkman WB, Leinbach RC, Buckley MJ, et al. Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation 1972;46:465-77.
16. Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300.
17. Himbert D, Juliard JM, Steg PG, Karrillon GJ, Aumont MC, Gourgon R. Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 1994;74:492-4.
18. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995;91:873-81.
19. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) multicenter trial of angioplasty for shock -(S)MASH. Eur Heart J 1999;20:1030-8.
20. Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). I Am Coll Cardiol 1998;31:1240-5.
21. Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: an observational study. Circulation 1997;96:122-7.
22. Menon V, Hochman JS, Holmes DR Jr, et al. Lack of progress in cardiogenic shock: lessons from the GUSTO trials. J Am Coll Cardiol 1998; 31:Suppl A:136A. abstract.
23. Hochman JS, Buller CE, Dzavik V, et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management, and outcome; overall results of the SHOCK Trial Registry. Circulation 1998;98:Suppl I: I-778. abstract.
24. Hochman JS, Sleeper LA, Godfrey E, et al. Should we emergency revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABG - trial design. Am Heart J 1999;137:313-21.
25. Armitage P. Restricted sequential procedures. Biometrika 1957;44:9-26.
26. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)
27. SAS system for Windows, version 6.12. Cary, N.C.: SAS Institute, 1996 (software).
28. S-PLUS for Windows, version 3.3. Seattle: Statistical Sciences, 1995 (software).
29. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987;76:142-54.
30. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336:1621-8. [Erratum, N Engl J Med 1997;337:287]
31. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-85.
32. Ross AM, Coyne KS, Moreyra E, et al. Extended mortality benefit of early postinfarction perfusion. Circulation 1998;97:1549-56.
33. Prewitt RM, Gu S, Schick U, Ducas J. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol 1994;23:794-8.
34. Stomel R, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105:997-1002.
35. Barron HV, Pirzada SR, Lomnitz DJ, Every NR, Gore JM, Chou TM. Use of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock. J Am Coll Cardiol 1998; 31:Suppl A:135A. abstract.
36. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
37. Hochman JS, Gersh BJ. Acute myocardial infarction: complications. In: Topol EJ, ed. Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven, 1998:437-80.